Mostrar el registro sencillo del ítem

dc.contributor.authorGarcía-González, P.*
dc.contributor.authorde Rojas, I.*
dc.contributor.authorMoreno-Grau, S.*
dc.contributor.authorMontrreal, L.*
dc.contributor.authorPuerta, R.*
dc.contributor.authorAlarcón-Martín, E.*
dc.contributor.authorQuintela García, Inés*
dc.contributor.authorOrellana, A.*
dc.contributor.authorAndrade, V.*
dc.contributor.authorAdami, P.V.M.*
dc.contributor.authorHeilmann-Heimbach, S.*
dc.contributor.authorGomez-Garre, P.*
dc.contributor.authorPeriñán, M.T.*
dc.contributor.authorAlvarez, I.*
dc.contributor.authorDiez-Fairen, M.*
dc.contributor.authorNuñez Llaves, R.*
dc.contributor.authorOlivé Roig, C.*
dc.contributor.authorGarcia-Ribas, G.*
dc.contributor.authorMenéndez-González, M.*
dc.contributor.authorMartínez, C.*
dc.contributor.authorAguilar, M.*
dc.contributor.authorBuongiorno, M.*
dc.contributor.authorFranco-Macías, E.*
dc.contributor.authorSaez, M.E.*
dc.contributor.authorCano, A.*
dc.contributor.authorBullido, M.J.*
dc.contributor.authorReal, L.M.*
dc.contributor.authorRodríguez-Rodríguez, E.*
dc.contributor.authorRoyo, J.L.*
dc.contributor.authorÁlvarez, V.*
dc.contributor.authorPastor, P.*
dc.contributor.authorPiñol-Ripoll, G.*
dc.contributor.authorMir, P.*
dc.contributor.authorLara, M.C.*
dc.contributor.authorPadilla, M.M.*
dc.contributor.authorSánchez-Juan, P.*
dc.contributor.authorCarracedo Álvarez, Ángel*
dc.contributor.authorValero, S.*
dc.contributor.authorHernandez, I.*
dc.contributor.authorTàrraga, L.*
dc.contributor.authorRamirez, A.*
dc.contributor.authorBoada, M.*
dc.contributor.authorRuiz, A.*
dc.date.accessioned2025-09-10T08:44:14Z
dc.date.available2025-09-10T08:44:14Z
dc.date.issued2023
dc.identifier.citationGarcía-González P, de Rojas I, Moreno-Grau S, Montrreal L, Puerta R, Alarcón-Martín E, et al. Mendelian Randomisation Confirms the Role of Y-Chromosome Loss in Alzheimer's Disease Aetiopathogenesis in Men. International Journal of Molecular Sciences. 2023;24(2).
dc.identifier.issn1422-0067
dc.identifier.otherhttps://portalcientifico.sergas.gal//documentos/63df0a686fdec82c4e7de8c8
dc.identifier.urihttp://hdl.handle.net/20.500.11940/21733
dc.description.abstractMosaic loss of chromosome Y (mLOY) is a common ageing-related somatic event and has been previously associated with Alzheimer's disease (AD). However, mLOY estimation from genotype microarray data only reflects the mLOY degree of subjects at the moment of DNA sampling. Therefore, mLOY phenotype associations with AD can be severely age-confounded in the context of genome-wide association studies. Here, we applied Mendelian randomisation to construct an age-independent mLOY polygenic risk score (mloy-PRS) using 114 autosomal variants. The mloy-PRS instrument was associated with an 80% increase in mLOY risk per standard deviation unit (p = 4.22 × 10?20) and was orthogonal with age. We found that a higher genetic risk for mLOY was associated with faster progression to AD in men with mild cognitive impairment (hazard ratio (HR) = 1.23, p = 0.01). Importantly, mloy-PRS had no effect on AD conversion or risk in the female group, suggesting that these associations are caused by the inherent loss of the Y chromosome. Additionally, the blood mLOY phenotype in men was associated with increased cerebrospinal fluid levels of total tau and phosphorylated tau181 in subjects with mild cognitive impairment and dementia. Our results strongly suggest that mLOY is involved in AD pathogenesis.
dc.description.sponsorshipP.G.-G. (Pablo Garcia-Gonzalez) is supported by CIBERNED employment plan CNV-304-PRF-866. CIBERNED is integrated into ISCIII (Instituto de Salud Carlos III). I.d.R is supported by a national grant from the Instituto de Salud Carlos III FI20/00215. A.C. (Amanda Cano) acknowledges the support of the Spanish Ministry of Science, Innovation, and Universities under the grant Juan de la Cierva (FJC2018-036012-I). M.B. (Merce Boada) and A.R. (Agustin Ruiz) are also supported by national grants PI13/02434, PI16/01861, PI17/01474, PI19/01240, and PI19/01301. The Genome Research @ Fundacio ACE project (GR@ACE) is supported by Grifols SA, Fundacion bancaria La Caixa, Fundacio ACE, and CIBERNED. Accion Estrategica en Salud is integrated into the Spanish National R?+?D?+?I Plan and funded by ISCIII (Instituto de Salud Carlos III)-Subdireccion General de Evaluacion-and the Fondo Europeo de Desarrollo Regional (FEDER-Una manera de hacer Europa). Genotyping of the ACE MCI-EADB samples was performed in the context of EADB (European Alzheimer DNA biobank) funded by the JPco-fuND FP-829-029 (ZonMW project number 733051061). This work was supported by a grant (European Alzheimer DNA BioBank, EADB) from the EU Joint Program-Neurodegenerative Disease Research (JPND).
dc.languageeng
dc.rightsAttribution 4.0 International (CC BY 4.0)*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshHumans *
dc.subject.meshMale *
dc.subject.meshFemale *
dc.subject.meshAlzheimer Disease *
dc.subject.meshChromosomes, Human, Y *
dc.subject.meshGenome-Wide Association Study *
dc.subject.meshMosaicism *
dc.subject.meshRisk Factors *
dc.subject.meshCognitive Dysfunction*
dc.subject.meshtau Proteins *
dc.subject.meshBiomarkers*
dc.subject.meshAmyloid beta-Peptides *
dc.titleMendelian Randomisation Confirms the Role of Y-Chromosome Loss in Alzheimer's Disease Aetiopathogenesis in Men
dc.typeArtigo
dc.authorsophosGarcía-González, P.; de Rojas, I.; Moreno-Grau, S.; Montrreal, L.; Puerta, R.; Alarcón-Martín, E.; Quintela, I.; Orellana, A.; Andrade, V.; Adami, P.V.M.; Heilmann-Heimbach, S.; Gomez-Garre, P.; Periñán, M.T.; Alvarez, I.; Diez-Fairen, M.; Nuñez Llaves, R.; Olivé Roig, C.; Garcia-Ribas, G.; Menéndez-González, M.; Martínez, C.; Aguilar, M.; Buongiorno, M.; Franco-Macías, E.; Saez, M.E.; Cano, A.; Bullido, M.J.; Real, L.M.; Rodríguez-Rodríguez, E.; Royo, J.L.; Álvarez, V.; Pastor, P.; Piñol-Ripoll, G.; Mir, P.; Lara, M.C.; Padilla, M.M.; Sánchez-Juan, P.; Carracedo, A.; Valero, S.; Hernandez, I.; Tàrraga, L.; Ramirez, A.; Boada, M.; Ruiz, A.
dc.identifier.doi10.3390/ijms24020898
dc.identifier.sophos63df0a686fdec82c4e7de8c8
dc.issue.number2
dc.journal.titleInternational Journal of Molecular Sciences*
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Fundación Pública Galega de Medicina Xenómica
dc.organizationFundación Pública Galega de Medicina Xenómica
dc.relation.projectIDCIBERNED [CNV-304-PRF-866]
dc.relation.projectIDInstituto de Salud Carlos III [FI20/00215]
dc.relation.projectIDSpanish Ministry of Science, Innovation, and Universities [FJC2018-036012-I]
dc.relation.projectIDGrifols SA
dc.relation.projectIDFundacion bancaria La Caixa
dc.relation.projectIDFundacio ACE
dc.relation.projectIDCIBERNED
dc.relation.projectIDISCIII (Instituto de Salud Carlos III)-Subdireccion General de Evaluacion
dc.relation.projectIDFondo Europeo de Desarrollo Regional (FEDER-Una manera de hacer Europa)
dc.relation.projectIDJPco-fuND FP-829-029 (ZonMW) [733051061]
dc.relation.projectIDEU Joint Program-Neurodegenerative Disease Research (JPND)
dc.relation.projectID[PI13/02434]
dc.relation.projectID[PI16/01861]
dc.relation.projectID[PI17/01474]
dc.relation.projectID[PI19/01240]
dc.relation.projectID[PI19/01301]
dc.relation.publisherversionhttps://doi.org/10.3390/ijms24020898
dc.rights.accessRightsopenAccess*
dc.subject.keywordAS Santiago
dc.subject.keywordFPGMX
dc.subject.keywordFPGMX
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)
dc.typesophosArtículo Original
dc.volume.number24


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution 4.0 International (CC BY 4.0)
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution 4.0 International (CC BY 4.0)